Compile Data Set for Download or QSAR
Report error Found 65 Enz. Inhib. hit(s) with all data for entry = 10469
TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538015(US11248006, Compound 3-5-1)
Affinity DataIC50: 2.40nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538003(US11248006, Compound 3-3-2)
Affinity DataIC50: 3.30nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM537991(US11248006, Compound 2-2-1)
Affinity DataIC50: 3.70nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538022(US11248006, Compound 3-7-5)
Affinity DataIC50: 3.90nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538035(US11248006, Compound 8-1-2)
Affinity DataIC50: 4.40nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538006(US11248006, Compound 3-3-5)
Affinity DataIC50: 4.80nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM537994(US11248006, Compound 3-1-1)
Affinity DataIC50: 4.90nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538030(US11248006, Compound 4-1-1)
Affinity DataIC50: 5.10nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM537985(US11248006, Compound 1-2-1)
Affinity DataIC50: 5.40nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538002(US11248006, Compound 3-3-1)
Affinity DataIC50: 5.5nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538004(US11248006, Compound 3-3-3)
Affinity DataIC50: 5.70nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538016(US11248006, Compound 3-5-2)
Affinity DataIC50: 6.10nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM537983(US11248006, Compound 1-1-5)
Affinity DataIC50: 6.10nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538010(US11248006, Compound 3-3-9)
Affinity DataIC50: 6.30nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538012(US11248006, Compound 3-3-11)
Affinity DataIC50: 6.5nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538028(US11248006, Compound 3-7-14)
Affinity DataIC50: 6.5nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538024(US11248006, Compound 3-7-15 | US11248006, Compound...)
Affinity DataIC50: 6.60nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM537978(US11248006, Compound 1-1-1)
Affinity DataIC50: 6.70nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM537984(US11248006, Compound 1-1-6)
Affinity DataIC50: 6.80nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM537981(US11248006, Compound 1-1-3)
Affinity DataIC50: 7.30nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538031(US11248006, Compound 5-1-1)
Affinity DataIC50: 7.5nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM537997(US11248006, Compound 3-2-3)
Affinity DataIC50: 7.60nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538018(US11248006, Compound 3-7-1)
Affinity DataIC50: 7.60nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538009(US11248006, Compound 3-3-8)
Affinity DataIC50: 7.60nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM537998(US11248006, Compound 3-2-5)
Affinity DataIC50: 7.70nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538024(US11248006, Compound 3-7-15 | US11248006, Compound...)
Affinity DataIC50: 7.90nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM537987(US11248006, Compound 1-3-1)
Affinity DataIC50: 8.10nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538014(US11248006, Compound 3-4-2)
Affinity DataIC50: 8.20nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538041(US11248006, Compound 10-1-3)
Affinity DataIC50: 8.40nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538027(US11248006, Compound 3-7-10)
Affinity DataIC50: 8.5nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538005(US11248006, Compound 3-3-4)
Affinity DataIC50: 8.60nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM50240826(AZD-1775 | MK-1775 | US11124518, Example AZD1775 |...)
Affinity DataIC50: 8.70nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent
PDB3D3D Structure (crystal)
TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538011(US11248006, Compound 3-3-10)
Affinity DataIC50: 8.80nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538001(US11248006, Compound 3-2-8)
Affinity DataIC50: 9nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538026(US11248006, Compound 3-7-9)
Affinity DataIC50: 9.20nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538013(US11248006, Compound 3-4-1)
Affinity DataIC50: 9.40nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538020(US11248006, Compound 3-7-3)
Affinity DataIC50: 9.5nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538023(US11248006, Compound 3-7-6)
Affinity DataIC50: 9.60nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538040(US11248006, Compound 10-1-1)
Affinity DataIC50: 9.90nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538000(US11248006, Compound 3-2-7)
Affinity DataIC50: 10.2nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM537986(US11248006, Compound 1-2-2)
Affinity DataIC50: 10.3nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM537999(US11248006, Compound 3-2-6)
Affinity DataIC50: 10.4nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM537992(US11248006, Compound 2-3-1)
Affinity DataIC50: 10.7nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM537996(US11248006, Compound 3-2-2)
Affinity DataIC50: 11nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538036(US11248006, Compound 8-2-1)
Affinity DataIC50: 11.6nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538042(US11248006, Compound 10-1-5)
Affinity DataIC50: 11.7nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538039(US11248006, Compound 9-1-1)
Affinity DataIC50: 11.8nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538025(US11248006, Compound 3-7-8)
Affinity DataIC50: 12.3nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538033(US11248006, Compound 7-1-1)
Affinity DataIC50: 12.9nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

TargetWee1-like protein kinase(Human)
Shanghai De Novo Pharmatech

US Patent
LigandPNGBDBM538037(US11248006, Compound 8-2-2)
Affinity DataIC50: 13nMAssay Description:In the present disclosure, Wee1 enzyme catalysis assay was carried out using the ATP-Glo Max kinase luminescence detection kit (Promega). Kinase acti...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/13/2022
Entry Details
US Patent

Displayed 1 to 50 (of 65 total ) | Next | Last >>
Jump to: